Tag Archives: patent

Civil society opposes patent on sofosbuvir

10 September, 2014- In a move towards furthering access to affordable medicines, Lawyers Collective through Sankalp Rehabilitation Trust, the Hepatitis Coalition of Nagaland and Network of PLHIV living in the Asia Pacific region (APN+), filed a pre- grant challenge to

Bombay High Court dismisses Bayer’s challenge- upholds Compulsory license on Nexavar

15.07.2014- In a momentous decision for patients, a Division Bench of the Bombay High Court dismissed a writ petition filed by Bayer challenging the IPAB order upholding the compulsory license granted to Natco for Sorafenib Tosylate (Nexavar). Nexavar is a

Indian Civil Society Members Urge Prime Minister to Resist US Administration Pressure

March 27, 2014 Dr. Manmohan Singh Hon’ble Prime Minister of India, The Prime Minister’s Office, South Block, Raisina Hill, New Delhi 110011. Tel: 011 23018939; Fax: 011 2301 0233. Email: manmohan@sansad.nic.in Resist the US administration Pressure and Reject the Misleading

Naz Foundation files Curative Petition challenging the Supreme Court judgment on Section 377

31st March, 2014: The Naz Foundation (India) Trust, the original petitioner in the constitutional challenge to Section 377, has filed a curative petition challenging the Supreme Court decision in Suresh Kumar Koushal v. Naz Foundation (hereinafter ‘Koushal’) delivered in December,

Valganciclovir: IPAB remands matter back to the Controller: patent to remain revoked

30th January, 2014: The Intellectual Property Appellate Board (IPAB) set aside the Patent Controller’s decision to revoke the patent relating to valganciclovir on technical grounds and remanded it to the Controller for re-consideration. In a significant development for patient groups,

Patent challenge

IT has been more than a year since the first compulsory licence was granted to an Indian company manufacturing generic drugs to produce a patented drug. In March 2012, the compulsory licence granted to Natco for manufacturing sorafenib tosylate (brand name Nexavar),

Lawyers Collective Response to Testimony of Mr. Roy F Waldron, Pfizer Inc.

Recently, several multinational pharmaceutical companies along with the US Chamber of Commerce have been instrumental in mounting pressure on India to decry the alleged state of Intellectual Property (IP) regime in India. On June 27, 2013 a hearing, ‘A tangle

More than safety, location of a nuclear plant should be considered first: Lawyer

COIMBATORE: A three-day national consultation committee on HIV/AIDS care and support to the patients, organised at the Karl Kubel Institute here in Annaikatti, concluded on Saturday. Among the speakers at the programme, was Anand Grover, an eminent lawyer and the United Nations Special Rapporteur of UN Human Rights wing. Grover, a practicing lawyer in